The impact of platinum-induced peripheral neuropathy (PN) in first-line treatment on PN and efficacy in second-line paclitaxel (PTX)-based chemotherapy for unresectable advanced gastric cancer (AGC): A prospective observational multicenter study - IVY study

被引：0
|
作者：
Kono, Y. [1 ]
Tanioka, H. [2 ]
Kito, Y. [3 ]
Ando, T. [4 ]
Negoro, Y. [5 ]
Abe, T. [6 ]
Kuramochi, H. [7 ]
Boku, S. [8 ]
Mannami, T. [9 ]
Nasu, J. [10 ]
Inoue, M. [11 ]
Nakamura, M. [12 ]
Okita, Y. [13 ]
Shindo, Y. [14 ]
Maeda, T. [15 ]
Shinohara, Y. [16 ]
Yano, S. [17 ]
Okawaki, M. [17 ]
Nagasaka, T. [17 ]
机构：
[1] Okayama Univ, Dept Gastroenterol & Hepatol, Grad Sch Med Dent & Pharmaceut Sci, Okayama, Japan
[2] Kawasaki Med Sch Hosp, Med Oncol Dept, Kurashiki, Okayama, Japan
[3] Ishikawa Prefectural Cent Hosp, Dept Med Oncol, Kanazawa, Ishikawa, Japan
[4] Toyama Univ Hosp, Dept Internal Med 3, Toyama, Japan
[5] Kochi Hlth Sci Ctr, Div Gastroenterol Med, Kochi, Japan
[6] Steel Mem Muroran Hosp, Dept Gastroenterol, Muroran, Hokkaido, Japan
[7] Tokyo Womens Med Univ, Dept Chemotherapy, Tokyo, Japan
[8] Kansai Med Univ, Canc Treatment Ctr, Hirakata, Osaka, Japan
[9] Natl Hosp Org Okayama Med Ctr, Dept Gastroenterol, Okayama, Japan
[10] Okayama Saiseikai Gen Hosp, Dept Internal Med, Okayama, Japan
[11] Okayama Red Cross Hosp, Dept Gastroenterol, Okayama, Japan
[12] Aizawa Hosp, Aizawa Comprehens Canc Ctr, Matsumoto, Nagano, Japan
[13] Kagawa Univ Hosp, Dept Clin Oncol, Miki, Kagawa, Japan
[14] Nakadori Gen Hosp, Dept Gastroenterol Surg, Akita, Japan
[15] Konko Hosp, Dept Surg, Asakuchi, Japan
[16] Japan Community Healthcare Org Kyushu Hosp, Dept Hematol Oncol, Kitakyushu, Fukuoka, Japan
[17] Kawasaki Med Sch Hosp, Dept Clin Oncol, Kurashiki, Okayama, Japan
来源：
ANNALS OF ONCOLOGY | 2023年 / 34卷
关键词：
D O I：
10.1016/j.annonc.2023.09.1497
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1585P
引用
收藏
页码：S883 / S883
页数：1
相关论文
共 50 条
  • [21] Fluoropyrimidine with or without platinum as first-line chemotherapy in patients with advanced gastric cancer and severe peritoneal metastasis: a multicenter retrospective study
    Hiroyuki Arai
    Satoru Iwasa
    Narikazu Boku
    Masahiro Kawahira
    Hirofumi Yasui
    Toshiki Masuishi
    Kei Muro
    Keiko Minashi
    Shuichi Hironaka
    Naoki Fukuda
    Daisuke Takahari
    Takako Eguchi Nakajima
    BMC Cancer, 19
  • [22] Fluoropyrimidine with or without platinum as first-line chemotherapy in patients with advanced gastric cancer and severe peritoneal metastasis: a multicenter retrospective study
    Arai, Hiroyuki
    Iwasa, Satoru
    Boku, Narikazu
    Kawahira, Masahiro
    Yasui, Hirofumi
    Masuishi, Toshiki
    Muro, Kei
    Minashi, Keiko
    Hironaka, Shuichi
    Fukuda, Naoki
    Takahari, Daisuke
    Nakajima, Takako Eguchi
    BMC CANCER, 2019, 19 (1)
  • [23] Second-Line Chemotherapy With Fluorouracil, Leucovorin, and Irinotecan (FOLFIRI Regimen) in Patients With Advanced Small Bowel Adenocarcinoma After Failure of First-Line Platinum-Based Chemotherapy A Multicenter AGEO Study
    Zaanan, Aziz
    Gauthier, Melanie
    Malka, David
    Locher, Christophe
    Gornet, Jean-Marc
    Thirot-Bidault, Anne
    Tougeron, David
    Taieb, Julien
    Bonnetain, Franck
    Aparicio, Thomas
    CANCER, 2011, 117 (07) : 1422 - 1428
  • [24] SECOND-LINE CHEMOTHERAPY WITH FLUOROURACIL, LEUCOVORIN, AND IRINOTECAN (FOLFIRI REGIMEN) IN PATIENTS WITH ADVANCED SMALL BOWEL ADENOCARCINOMA AFTER FAILURE OF FIRST-LINE PLATINUM-BASED CHEMOTHERAPY: A MULTICENTER AGEO STUDY
    Aparicio, T.
    Zaanan, A.
    Gauthier, M.
    Malka, D.
    Locher, C.
    Gornet, J.
    Thirot-Bidault, A.
    Tougeron, D.
    Taieb, J.
    Bonnetain, F.
    ANNALS OF ONCOLOGY, 2010, 21 : 238 - 238
  • [25] Clinical efficacy and safety of apatinib combined with docetaxel in second-line treatment for advanced gastric cancer: A prospective study.
    Yang, Mudan
    Gao, Jun
    Xu, Zhou
    Lu, Hongxia
    Yang, Wenhui
    Li, Li
    Li, Hui
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [26] Second-line treatment options in advanced thymic carcinoma after failure of platinum-based chemotherapy: A multicenter retrospective study
    Wang, Yang
    Zhang, Xuanye
    Tian, Dan
    Han, Sen
    Zhang, Jie
    Nie, Jun
    Dai, Ling
    Hu, Weiheng
    Chen, Xiaoling
    Ma, Xiangjuan
    Tian, Guangming
    Wu, Di
    Zhang, Ziran
    Long, Jieran
    Fang, Jian
    CANCER MEDICINE, 2023, 12 (03): : 2303 - 2311
  • [27] RANDOMIZED PHASE II STUDY OF BELOTECAN OR TOPOTECAN CHEMOTHERAPY AS SECOND-LINE CHEMOTHERAPY AFTER PLATINUM-BASED FIRST-LINE CHEMOTHERAPY FOR SMALL CELL LUNG CANCER
    Yoon, S.
    Lee, D. H.
    Choi, C.
    Lee, J. C.
    Lee, J. S.
    Kim, S.
    ANNALS OF ONCOLOGY, 2014, 25
  • [28] Efficacy and toxicity of FOLFOX-4 as a second-line chemotherapy in locally advanced unresectable and metastatic carcinoma gall bladder: A prospective observational study.
    Dodagoudar, Chandragouda
    Mahanta, Anupam
    Goswami, Vikas
    Goel, Varun
    Doval, Dinesh C.
    Talwar, Vineet
    Batra, Ullas
    Singh, Sajjan
    Chauhan, Deepika
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [29] Nab-paclitaxel as second-line treatment in advanced gastric cancer: a multicenter phase II study of the Hellenic Oncology Research Group
    Katsaounis, Panagiotis
    Kotsakis, Athanasios
    Kentepozidis, Nikolaos
    Polyzos, Aris
    Bakogeorgos, Marios
    Koinis, Filippos
    Vamvakas, Lambros
    Vardakis, Nikolaos
    Kalbakis, Kostas
    Boukovinas, Ioannis
    Varthalitis, Ioannis I.
    Prinarakis, Efthimios
    Georgoulias, Vassilis
    Souglakos, John
    ANNALS OF GASTROENTEROLOGY, 2018, 31 (01): : 65 - 70
  • [30] Multicenter phase I/II study of nivolumab combined with paclitaxel plus ramucirumab as the second-line treatment in patients with advanced gastric cancer
    Kadowaki, S.
    Izawa, N.
    Minashi, K.
    Nishina, T.
    Yamanaka, T.
    Muro, K.
    Sunakawa, Y.
    Hironaka, S.
    Kajiwara, T.
    Kawakami, Y.
    Nakajima, T.
    ANNALS OF ONCOLOGY, 2019, 30
12345